Company profile
BGV (BioGeneration Ventures)
Early-stage funding for European life sciences companies
- Industry
- Venture Capital and Private Equity Principals
- Employees
- 44
- Headquarters
- Naarden
- Founded
- 2006
- Office locations
- 1
BGV (BioGeneration Ventures) company summary
BGV (BioGeneration Ventures) is a company in the Venture Capital and Private Equity Principals industry, headquartered in Naarden, founded in 2006. On LinkedIn the company has around 44 employees. Its listed specialties include Venture Capital, Start-up companies, Life Sciences, Biotech, Medtech.
What technology does BGV (BioGeneration Ventures) use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About BGV (BioGeneration Ventures)
BioGeneration Ventures (BGV) is a venture capital company, with a focus on early stage European biotech, medtech, and diagnostics companies. BGV has a strong track record of significant financial returns through investing in innovations in healthcare and providing the expertise to build world-class teams. The Company manages over €100 million of funds investing in areas where true scientific innovations, the unmet medical need, and the potential to demonstrate a significant proof of concept all come together. BGV strives to work with founding teams to mature science and build companies. The Company uses its experience to guide progress into clinical trials, ultimately leading to successful drug development and value realisation for its investors. BGV applies its expertise in a rigorous process to select the most compelling opportunities with the best prospects for exit. Historical successful investments include divestment of Dezima Pharma to Amgen for up to USD 1.55 billion in total deal value and in Acerta Pharma for up to USD 7 billion with a guaranteed payment of USD 4 billion. Both companies were co-founded by BGV in 2012 and 2013 respectively. The Acerta Pharma sale was the largest exit ever of a privately held European biotech company. BGV is based in Naarden, The Netherlands, and closely collaborates with Forbion.
Specialties
Where is BGV (BioGeneration Ventures) located?
BGV (BioGeneration Ventures) lists 1 location.
Compare companies similar to BGV (BioGeneration Ventures)
More companies in Venture Capital and Private Equity Principals.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
BGV (BioGeneration Ventures) biogenerationventures.com | Venture Capital and Private Equity Principals | 44 | 2006 | Naarden |
 Sequoia Capital sequoiacap.com | Venture Capital and Private Equity Principals | 347 | - | Menlo Park, CA |
 Andreessen Horowitz a16z.com | Venture Capital and Private Equity Principals | 1,030 | 2009 | Menlo Park, CA |
 Private Equity Insights pe-insights.com | Venture Capital and Private Equity Principals | 1,579 | 2013 | London, England |
 500 Global 500.co | Venture Capital and Private Equity Principals | 2,686 | 2010 | Palo Alto, California, US |
 Techstars techstars.com | Venture Capital and Private Equity Principals | 2,610 | 2006 | New York City, New York |
 Accel accel.com | Venture Capital and Private Equity Principals | 1,411 | - | Palo Alto, CA |
 Virgin virgin.com | Venture Capital and Private Equity Principals | 36,222 | - | London, England |
 Conscience VC conscience.vc | Venture Capital and Private Equity Principals | 2,001 | 2020 | Austin, TX |
 Peak XV Partners peakxv.com | Venture Capital and Private Equity Principals | 206 | - | Bangalore, Karnataka, IN |
 Greylock Partners greylock.com | Venture Capital and Private Equity Principals | 132 | - | Menlo Park, CA, US |
Frequently asked questions about BGV (BioGeneration Ventures)
What does BGV (BioGeneration Ventures) do?
BioGeneration Ventures (BGV) is a venture capital company, with a focus on early stage European biotech, medtech, and diagnostics companies. BGV has a strong track record of significant financial returns through investing in innovations in healthcare and providing the expertise to build world-class teams. The Company manages over €100 million of funds investing in areas where true scientific innovations, the unmet medical need, and the potential to demonstrate a significant proof of concept all come together. BGV strives to work with founding teams to mature science and build companies. The Company uses its experience to guide progress into clinical trials, ultimately leading to successful drug development and value realisation for its investors. BGV applies its expertise in a rigorous process to select the most compelling opportunities with the best prospects for exit. Historical successful investments include divestment of Dezima Pharma to Amgen for up to USD 1.55 billion in total deal value and in Acerta Pharma for up to USD 7 billion with a guaranteed payment of USD 4 billion. Both companies were co-founded by BGV in 2012 and 2013 respectively. The Acerta Pharma sale was the largest exit ever of a privately held European biotech company. BGV is based in Naarden, The Netherlands, and closely collaborates with Forbion.
How many employees does BGV (BioGeneration Ventures) have?
BGV (BioGeneration Ventures) has around 44 employees on LinkedIn.
Where is BGV (BioGeneration Ventures) headquartered?
BGV (BioGeneration Ventures) is headquartered in Naarden.
When was BGV (BioGeneration Ventures) founded?
BGV (BioGeneration Ventures) was founded in 2006.
Build a lead list from companies like BGV (BioGeneration Ventures)
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.